10x Genomics sued Element Biosciences, alleging Element’s Aviti24 multiomic platform infringes 10x spatial technology patents licensed from Harvard University. The complaint was filed in the US District Court for the District of Delaware and targets multiple patents covering analyte detection methods and related sequencing approaches. 10x seeks monetary damages, attorneys’ fees, and a permanent injunction. Element said it strongly disagrees with the allegations, arguing the suit reflects a broader pattern of using a shared patent portfolio to constrain innovation, and said it will defend the claims. Aviti24 is positioned by Element for single-assay capture of RNA, protein, morphology, spatial context, and dynamic response, and Element has indicated plans for in-tissue spatial sequencing offerings on the platform later this year.